# Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension

> **NCT00136851** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 259 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** amlodipine besylate/benazepril hydrochloride

## Key facts

- **NCT ID:** NCT00136851
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2011-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136851, "Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00136851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*